Executive Insights

Minimally invasive surgical (MIS) products are a staple of todays spine company portfolios. In anticipation of new devices to be...

Device companies are prioritizing supply chain alignment to achieve company vision, leverage expertise and obtain significant cost savings. For insight...

The Chinese government has prioritized medical device development, as well as local and international investments by domestic device companies. Whether...

How device manufacturers, surgeons and insurance companies are shaping the future of sustainable medicine. ...

The use of computer-assisted surgery systems that incorporate robotics, surgical planning and navigation have the potential to bring reproducible results...

Post-surgical infection control is a priority in the reduction of complications, revisions and costs. It's a topic of importance along...

The arthroscopy/soft tissue segment reached sales of $4.5 billion in 2015, a four percent increase over 2014, according to ORTHOWORLD...

As declining margins squeeze every facet of orthopaedics and reimbursement undergoes yet another change, independent surgeons seek to diversify their...

The advent of the Centers for Medicare & Medicaid's Comprehensive Care for Joint Replacement (CJR) program fueled AAOS Annual Meeting...

The capital associated with instrument sets is significant and, to some companies, somewhat unknown once inventory enters the field. As...